John R. Palumbo serves as Executive at Lucid Diagnostics Inc., where they oversee executive responsibilities. Since joining the company, John R. Palumbo has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 20, 2026 involved receiving (via award) 123,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 20, 2026 | LUCD | $0 | Award | 123,000 | $N/A | Discretionary |
John R. Palumbo currently holds 338,000 shares of Lucid Diagnostics Inc. (LUCD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John R. Palumbo has been a net neutral trader of LUCD stock. They have purchased $0 and sold $0 worth of shares.
John R. Palumbo's most recent insider trade was on Feb 20, 2026, when they sold 123,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted